BRIEF published on 07/08/2024 at 16:20, 1 year 9 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 1 year 9 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 04/25/2026 at 03:10, 1 day 13 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 1 day 18 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 1 day 18 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 2 days 1 hour ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 2 days 1 hour ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/26/2026 at 10:20, 5 hours 53 minutes ago EQS-Adhoc: Vitruvia Medical AG: Annual Results as of December 31, 2025
Published on 04/26/2026 at 09:05, 7 hours 8 minutes ago Natural Expressions Unveils Performance 7: The Era of "Drop-and-Mow" Wireless Robotic Mowing Arrives in Europe
Published on 04/25/2026 at 16:25, 23 hours 48 minutes ago Leading a New Era of Family Mobility! CHERY TIGGO V, the 3-in-1 Family Vehicle, Debuts at AutoChina2026
Published on 04/24/2026 at 22:43, 1 day 17 hours ago EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 1 day 18 hours ago Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 17:45, 1 day 22 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 1 day 23 hours ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 2 days 20 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 2 days 21 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
